US vaccine panel no longer recommends Covid-19 jab to adults

The US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) has updated its recommendations regarding several vaccines, including the COVID-19 vaccine for adults. The ACIP no longer recommends the COVID-19 vaccine for most adults, citing a decrease in severe disease and the availability of treatments. However, the committee still recommends the vaccine for certain high-risk groups, such as immunocompromised individuals. Additionally, the ACIP has changed its recommendation on the MMRV (measles, mumps, rubella, and varicella) vaccine, advising against its use in favor of separate MMR and varicella vaccines. The committee has also delayed a vote on the hepatitis B vaccine, citing the need for further review. These updates reflect the ongoing evaluation of vaccine recommendations based on evolving scientific evidence and the changing landscape of the COVID-19 pandemic. The ACIP's recommendations serve as guidance for healthcare providers and policymakers in the United States.